Search Criteria : United States of America × Pasadena ×
Oct 30 - Nov 01, 2020 | CME : 13 | MOC : 13 | Contact Hours : 13 | CEUs : 1.3 | USD $275.00 | Pasadena, California
16th Annual California Cancer Consortium Conference (CCC): “Recent Advances and New Directions in Cancer Therapy” is organized by Meetings Events & Conference Coordinators, (MECC). This onsite medical conference will be held from Oct 30 - Nov 01, 2020, at The Langham, Huntington, Pasadena, Pasadena, California, United States of America. Who should attend? This CME conference is intended for the medical oncologists, hematologists, surgical oncologists, radiation oncologists, diagnostic radiologists, pulmonologists, urologists, gastroenterologists, pathologists, fellow and resident trainees, advanced care practitioners, registered nurses, physician assistants, pharmacists, clinical research coordinators, biostatisticians, and others involved in oncologic drug development and clinical care. Accreditation and Designation Statements Physician: The Medical Educator Consortium assigns this live activity for a maximum of 13.0 AMA PRA Category 1 Credit(s)™. Physicians can earn the credit commensurate with the extent of their participation in the activity. MOC: "On Successful completion of this CME activity, a participant will be able to apply for the evaluation component, enabling a participant to receive up to 13.0 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.” Nursing: The Medical Educator Consortium assigns this activity for 13.0 contact hours. Pharmacotherapy contact hours for Advance Practice Registered Nurses will be designated on your certificate. Pharmacist: This Application-based activity has been approved for 13.0 contact hours (1.3 CEUs) by the Medical Educator Consortium. The Universal Activity Number for this program is JA4008179-0000-20-020-L01-P. Pharmacists are required to complete the evaluation AND provide NABP ID and Date of birth in dd/mm format within the time frame allotted to claim CE credit for the activity. Upon submission, your CE credits will be electronically submitted by MEC to CPE Monitor® within 60 days upon the successful completion of the activity. ANY submissions after the allotted time frame will not be reported to CPE Monitor®. Physician Assistant: NCCPA accepts AAPA Category 1 Credit from organizations accredited by ACCME or a recognized state medical society. PAs may claim a maximum of 13.0 Category 1 credits for completing this activity. What is the significance of 16th Annual California Cancer Consortium Conference (CCC)? Course Description: This conference aims to provide up-to-date information to the clinician regarding new advances in cancer biology, diagnosis, and treatment. It will bring together the interprofessional team that includes, respected opinion leaders, practicing clinicians, and scientists engaged in clinical cancer research to discuss the latest cancer diagnostic and therapeutic advances. Topics focus on the major cancers and drug development areas, including signal transduction/CDK inhibition, angiogenesis inhibition, PI3K/mTOR inhibition, antibody-drug conjugates, and immunotherapy, among others. This annual conference also includes interactive roundtable discussion forums with participation of cancer care experts from the California Cancer Consortium and features renowned professionals from academia patient advocacy, government, payer, industry, and business realms of cancer care. What are the objectives of the 16th Annual California Cancer Consortium Conference (CCC)? Conference Objectives At the conclusion of this CME educational activity, you should be able to: • Identify signaling and immunotherapeutic pathways that are involved in the growth and metastases of various tumor types. • Recognize specific opportunities for therapeutic intervention using an interprofessional team-based approach. • Describe recent advances in the molecular phenotyping of cancer and relate these to the optimal management of patients with cancer. • Based on recent clinical trials, assess the efficacy of novel therapeutic strategies in the treatment of patients with cancer. • Discuss new and emerging clinical trial designs that can test and validate new therapeutic strategies for cancer patients.
Mar 18 - 21, 2021 | Pasadena, California
CANP 44th Annual Educational Conference is organized by California Association for Nurse Practitioners (CANP). This Onsite medical conference will be held from Mar 18 - 21, 2021 at Pasadena Convention Center, Pasadena, California, United States of America. Additional details will be posted as soon as information is available.
Jun 10 - 11, 2021 | Pasadena, California
28th Annual USC National Trauma, Emergency Surgery and Acute Care Symposium is organized by Keck School of Medicine of the University of Southern California (USC) and will be held from Jun 10 - 11, 2021 at The Langham, Huntington, Pasadena, Pasadena, California, United States of America. Additional details will be posted as soon as information is available.